UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029877
Receipt number R000034128
Scientific Title A study examining the influence of fragrances using eye mask under warming therapies on daily emotion and self-reported sleep quality in subject who tends to lower the quality of sleep
Date of disclosure of the study information 2017/11/21
Last modified on 2019/05/10 14:00:48

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study examining the influence of fragrances using eye mask under warming therapies on daily emotion and self-reported sleep quality in subject who tends to lower the quality of sleep

Acronym

A study examining the influence of fragrances using eyemask under warming therapies on daily emotion and self-reported sleep quality

Scientific Title

A study examining the influence of fragrances using eye mask under warming therapies on daily emotion and self-reported sleep quality in subject who tends to lower the quality of sleep

Scientific Title:Acronym

A study examining the influence of fragrances using eyemask under warming therapies on daily emotion and self-reported sleep quality

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine whether fragrances under warming therapies using eye mask improve daily emotion and self-reported sleep quality on daily emotion and self-reported sleep quality

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The improvement of mood state using visual analog scale

Key secondary outcomes

Self-reported sleep quality
Sleep quality examination with Actiwatch


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration

Institution is not considered as adjustment factor.

Blocking


Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

No treatment (first day) ->Treatment A (three days/first week)->Treatment B (three days/second week)
Treatment A: Appling a test product before sleeping
Treatment B: Appling a placebo product before sleeping.

Interventions/Control_2

No treatment (first day) ->Treatment B(three days/first week)->Treatment A (three days/second week)
Treatment A: Appling a test product before sleeping
Treatment B: Appling a placebo product before sleeping

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

45 years-old <=

Age-upper limit

75 years-old >=

Gender

Female

Key inclusion criteria

Healthy females
With unsatisfactory state about the quality of daily sleep

Key exclusion criteria

1)Subjects who dislike perfumed products
2)Subjects who takes sleeping pills
3)Subjects who have chronic heart failure, chronic respiratory disease, renal failure and diabetes
4)Subjects who are pregnancy and suspected pregnancy

Target sample size

24


Research contact person

Name of lead principal investigator

1st name Yoshihiro
Middle name
Last name Hasegawa

Organization

Kao Corporation

Division name

Perfumery Development Research

Zip code

131-8501

Address

2-1-3, Bunka Sumida-ku, Tokyo

TEL

+81-3-5630-9437

Email

Hasegawa.yoshihiro@kao.co.jp


Public contact

Name of contact person

1st name Yuka
Middle name
Last name Nakamura

Organization

Kao Corporation

Division name

Perfumery Development Research

Zip code

131-8501

Address

2-1-3, Bunka Sumida-ku, Tokyo

TEL

+81-3-5630-9465

Homepage URL


Email

Nakamura.yuka2@kao.co.jp


Sponsor or person

Institute

Kao Corporation

Institute

Department

Personal name



Funding Source

Organization

Kao Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kao corporation

Address

2-1-3 BUnka Sumida-ku

Tel

+81-3-5630-9220

Email

uesaka.toshio@kao.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 11 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

21

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 10 Month 31 Day

Date of IRB

2017 Year 10 Month 31 Day

Anticipated trial start date

2017 Year 11 Month 21 Day

Last follow-up date

2017 Year 12 Month 26 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 11 Month 08 Day

Last modified on

2019 Year 05 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034128


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name